The experimental investigations of ARID1A inactivation in cellular and mouse models have revealed that ARID1A acts as a tumor suppressor during the initiation and progression stages of carcinogenesis in gynecological [13], liver [14], and colorectal cancer models [15]. Here, ARID1A is linked to neoplasm.